EQ Equillium Inc: Bozor kapitallashuvining balans qiymatiga nisbati
Equillium, Inc. (EQ) ning kunlik narxlar dinamikasi ilgari davolab bo'lmaydigan patologiyalardagi yallig'lanish jarayonlarini jilovlash uchun antitanachalar yaratishga yo'naltirilgan biznesning rivojlanishini aks ettiradi. Aktiv qiymati itolizumab muvaffaqiyati va global hamkorlardan kelgan kapital oqimlari hisobiga 1.55 miqdorida oshdi. Monoklonal oqsillar uchun mustaqil tadqiqot sikli doirasida faoliyat yuritish tashqi iqtisodiy zarbalarning klinik sinovlar sur'atiga ta'sirini minimallashtiradi.
%20Bozor%20kapitallashuvining%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_EQ_-_Equillium-Inc._-_Market-Capitalization-to-Book-Value-Ratio "Equillium (EQ) - Bozor qiymatining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha | 👁️GURU.Markets👁️")
Equillium, Inc. (EQ) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning dastlabki tahlili:Equillium Inc (EQ)
Immunologlarning Equillium, Inc. (EQ) tomonidan yallig'lanish terapiyasi sohasidagi ishlanmalariga bo'lgan ishonchi yuqori bozor brend premiumini yaratadi. Ushbu narx-kitob qiymati koeffitsiyenti kompaniyaning bozor qiymati va uning moddiy aktivlari o'rtasidagi farqni o'lchaydi. Ushbu koeffitsiyent dinamikasini tahlil qilish spekulyativ ortiqcha kapitalning barqarorligini baholash imkonini beradi. Kompaniyaning narx-kitob qiymati koeffitsiyenti tendentsiyasining barqarorligi investorlarning fundamental ishonchini tasdiqlaydi. Aktiv yuqori texnologiyali biofarmatsevtika qimmatqog'ozlari toifasiga kiradi.
Toʻgʻridan-toʻgʻri raqobatchilar
Bozor kapitallashuvining balans qiymatiga nisbati argenx SE ARGX|biontech.de (BNTX) - Balans qiymatiga nisbatan bozor qiymati|ABVX (abivax.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ADMA|Protagonist Therapeutics Inc (PTGX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IMVT (Immunovant Therapeutics)|Kiniksa Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati grifols.com GRFS|Adaptive Biotechnologies Corporation - Bozor kapitallashuvining balans qiymatiga nisbati|Celldex Therapeutics Inc (CLDX) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Aurinia Pharma AUPH|BioCryst Corp (BCRX) - Balans qiymatiga nisbatan bozor qiymati|VERA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi DNTH|Bozor qiymatining balans qiymatiga nisbati PHVS (Pharvaris)|Kapitallashuvning sof aktivlarga nisbati ABCL (AbCellera Biologics)|Tourmaline Corp - Bozor qiymatining balans qiymatiga nisbati|PGEN - Kapitallashuvning sof aktivlarga nisbati|Pharming Group N.V. - Kapitallashuvning sof aktivlarga nisbati|NKTR: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Upstream Bio|Zenas Bio (ZBIO) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IMNM (Immunome Corp)|Bozor qiymatining balans qiymatiga koeffitsiyenti Gossamer Bio Corp.|KalVista Pharmaceuticals - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SEPN (septerna.com)|PVLA (Pieris Pharmaceuticals, Inc.) - Bozor qiymatining balans qiymatiga nisbati|SVRA - Bozor qiymatining xususiy kapitalga nisbati|Rigel Pharmaceuticals Inc - Kapitallashuvning sof aktivlarga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|Astria Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ENGN (engene.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati JBIO|Bozor qiymatining balans qiymatiga nisbati Aclaris (ACRS)|Bozor qiymatining balans qiymatiga nisbati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati TLSA|CABA - Balans qiymatiga nisbatan bozor kapitallashuvi|Ventyx Biosciences, Inc. - Kapitallashuvning sof aktivlarga nisbati|THTX: Bozor kapitallashuvining balans qiymatiga nisbati|AVTX (Avalo Therapeutics Inc.) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Eledon Pharmaceuticals, Inc|AGEN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati climbbio.com|ZURA (Zura Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ATYR (aTyr Pharma Inc)|ADAG - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati ImageneBio IMA|STTK: Bozor kapitallashuvining balans qiymatiga nisbati|Connect Biopharma (CNTB) - Kapitallashuvning sof aktivlarga nisbati|immunic-therapeutics.com - Kapitallashuvning sof aktivlarga nisbati|Atara Bio (ATRA) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati IFRX (InflaRx NV)|Bozor qiymatining balans qiymatiga koeffitsiyenti XFOR|ACET: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati CELU (celularity.com)|INmune Bio (INMB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Barinthus Biotherapeutics PLC BRNS|Bozor kapitallashuvining balans qiymatiga nisbati Kezar Life Sciences, Inc (KZR)|SABS - Balans qiymatiga nisbatan bozor qiymati|AKTX: Bozor kapitallashuvining balans qiymatiga nisbati|ENLV (Enlivex Therapeutics Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|QTTB - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GOVX|Bozor qiymatining balans qiymatiga nisbati EDSA (Edesa)|Kapitallashuvning sof aktivlarga nisbati iBio Corporation (IBIO)|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|XTLB - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Bolt Bio (BOLT)|HCWB - Balans qiymatiga nisbatan bozor qiymati|aptevotherapeutics.com - Bozor kapitallashuvining balans qiymatiga nisbati|AIM (aimimmuno.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati ADTX|Kapitallashuvning sof aktivlarga nisbati GRI|Bozor qiymatining balans qiymatiga nisbati XRTX (XORTX Therapeutics)|Kapitallashuvning sof aktivlarga nisbati Vyome Holdings Inc. HIND|Kapitallashuvning sof aktivlarga nisbati REVB (Revelation Bio)|Indaptus Corp - Bozor kapitallashuvining balans qiymatiga nisbati|Scinai Immunotherapeutics (SCNI) - Bozor qiymatining balans qiymatiga nisbati|CALI - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AFMD|Allakos (ALLK) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati HOOK (HOOKIPA Pharma, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti IGMS|ITOS: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining xususiy kapitalga nisbati oceanbiomedical.com OCEA|Kapitallashuvning sof aktivlarga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD